Lurasidone Hydrochloride
Tier B — Position earlyLurasidone Hydrochloride · all drugs expiring in 2028 →
Targets:5-HT7, 5-HT2A, 5-HT1A, DRD2
Brand:Latuda
Indications (approved):Major depressive disorder, Schizophrenia, Mania, Depressive disorder
Regional status
Factories producing this API1
Factories registered as producing this API in our sourcing network (RFQ records + product master), sorted by RFQ activity; the snapshot carries no cost or customer data.
1 producing factories on file — sign in to view the named list (factory details are not shown to guests).
Sign in to view factories →Synthetic routes & intermediates6 routes
Routes are ordered originator first, then optimised / process (non-patent) routes; each lists steps, overall yield and the intermediate table (code / CAS / name) — ready for supplier sourcing and RFQ. Rendered by this site from structured data; no third-party route graphics used.

| Code | CAS No. | Intermediate |
|---|---|---|
| LURA-004 | 87691-87-0 | 3-(piperazin-1-yl)benzo[d]isothiazole |
| LURA-005 | - | (3aR,7aR)-4'-(benzo[d]isothiazol-3-yl)octahydrospiro[isoindole-2,1'-piperazin]-2-ium methanesulfonate |
| LURA-006 | 2054161-88-3 | (3aR,4S,7R,7aS)-hexahydro-1H-4,7-methanoisoindole-1,3(2H)-dione |
| LURA-001 | 71749-03-6 | (3aR,7aR)-hexahydroisobenzofuran-1,3-dione |
| LURA-002 | 65376-05-8Available | ((1R,2R)-cyclohexane-1,2-diyl)dimethanol |
| LURA-003 | 186204-35-3Available | ((1R,2R)-cyclohexane-1,2-diyl)bis(methylene) dimethanesulfonate |

| Code | CAS No. | Intermediate |
|---|---|---|
| LURA-007 | 110-17-8Available | fumaric acid |
| LURA-008 | 77-79-2 | 2,5-dihydrothiophene 1,1-dioxide |
| LURA-009 | 88-98-2 | cyclohex-4-ene-1,2-dicarboxylic acid |
| LURA-010 | 1687-30-5 | cyclohexane-1,2-dicarboxylic acid |
| LURA-011 | 58574-95-1 | (R)-1-phenylethan-1-aminium (1R,2S)-2-carboxycyclohexane-1-carboxylate |
| LURA-012 | 2305-32-0 | (1R,2S)-cyclohexane-1,2-dicarboxylic acid |

| Code | CAS No. | Intermediate |
|---|---|---|
| LURA-004 | 87691-87-0 | 3-(piperazin-1-yl)benzo[d]isothiazole |
| LURA-013 | 1421374-92-6 | ((1R,2R)-2-(aminomethyl)cyclohexyl)methanol |
| LURA-014 | 1792220-25-7 | (3aR,4S,7R,7aS)-hexahydro-4,7-methanoisobenzofuran-1,3-dione |
| LURA-015 | 1421374-93-7 | (3aR,4S,7R,7aS)-2-(((1R,2R)-2-(hydroxymethyl)cyclohexyl)methyl)hexahydro-1H-4,7-methanoisoindole-1,3(2H)-dione |
| LURA-016 | 1421374-94-8 | ((1R,2R)-2-(((3aR,4S,7R,7aS)-1,3-dioxooctahydro-2H-4,7-methanoisoindol-2-yl)methyl)cyclohexyl)methyl methanesulfonate |

| Code | CAS No. | Intermediate |
|---|---|---|
| LURA-006 | 2054161-88-3 | (3aR,4S,7R,7aS)-hexahydro-1H-4,7-methanoisoindole-1,3(2H)-dione |
| LURA-017 | 186204-35-3Available | ((1R,2R)-cyclohexane-1,2-diyl)bis(methylene) dimethanesulfonate |
| LURA-018 | 111-42-2 | 2,2'-azanediylbis(ethan-1-ol) |
| LURA-019 | - | ((1R,2R)-2-((bis(2-hydroxyethyl)amino)methyl)cyclohexyl)methyl methanesulfonate |
| LURA-020 | 1421374-97-1 | (3aR,4S,7R,7aS)-2-(((1R,2R)-2-((bis(2-hydroxyethyl)amino)methyl)cyclohexyl)methyl)hexahydro-1H-4,7-methanoisoindole-1,3(2H)-dione |
| LURA-021 | 1421374-98-2 | ((((1R,2R)-2-(((3aR,4S,7R,7aS)-1,3-dioxooctahydro-2H-4,7-methanoisoindol-2-yl)methyl)cyclohexyl)methyl)azanediyl)bis(ethane-2,1-diyl) dimethanesulfonate |
| LURA-022 | 23031-78-9 | benzo[d]isothiazol-3-amine |

| Code | CAS No. | Intermediate |
|---|---|---|
| LURA-004 | 87691-87-0 | 3-(piperazin-1-yl)benzo[d]isothiazole |
| LURA-005 | - | (3aR,7aR)-4'-(benzo[d]isothiazol-3-yl)octahydrospiro[isoindole-2,1'-piperazin]-2-ium methanesulfonate |
| LURA-006 | 2054161-88-3 | (3aR,4S,7R,7aS)-hexahydro-1H-4,7-methanoisoindole-1,3(2H)-dione |
| LURA-017 | 186204-35-3Available | ((1R,2R)-cyclohexane-1,2-diyl)bis(methylene) dimethanesulfonate |

| Code | CAS No. | Intermediate |
|---|---|---|
| LURA-024 | 14805-29-9Available | exo-Hexahydro-1H-4,7-methanoisoindole-1,3(2H)-dioneexo-Norbornane-2,3-dicarboximide |
| LURA-023 | - | [(1R,2R)-2-[[4-(1,2-Benzothiazol-3-yl)piperazin-1-yl]methyl]cyclohexyl]methyl methanesulfonate |
Frequently asked questions
What are the approved indications of Lurasidone Hydrochloride?
Approved indications include: Major depressive disorder, Schizophrenia, Mania, Depressive disorder.
When does the Lurasidone Hydrochloride patent expire?
Based on public sources, the Lurasidone Hydrochloride patent expires in 2028.
How many synthesis routes are recorded for Lurasidone Hydrochloride?
6 synthesis routes are recorded; the shortest is 1 steps with 4.5 g (Lurasidone) total yield. Intermediates in each route carry codes and CAS numbers.
Where can I buy Lurasidone Hydrochloride intermediates?
4 intermediate CAS of Lurasidone Hydrochloride are available through the Unibest supply network — see the route tables on this page and request a quote per CAS.
How do I get a quote for Lurasidone Hydrochloride intermediates?
Open the CAS profile of the target intermediate from this page, or submit an RFQ directly — the CAS enters the matching flow automatically and the supply network responds with quotes.
Source: cross-verified data (structured fields only) · 2026-09-29